AbCellera Biologics
(NASDAQ) ABCL
AbCellera Biologics Financials at a Glance
Market Cap
$1.62B
Revenue (TTM)
$79.21M
Net Income (TTM)
-$143.96M
EPS (TTM)
-$0.48
P/E Ratio
-11.05
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$5.10
Volume
226,639
Open
$5.21
Price
$5.10
Volume
226,639
Open
$5.21
Previous Close
$5.10
Daily Range
$5.10 - $5.47
52-Week Range
$2.75 - $6.79
Estimated Earnings Date
Aug 6, 2026
Dividend
$0.00
Beta (Volatility)
1.42 (Average)
Price
$5.10
Volume
226,639
Open
$5.21
Previous Close
$5.10
Daily Range
$5.10 - $5.47
52-Week Range
$2.75 - $6.79
Estimated Earnings Date
Aug 6, 2026
ABCL News
ABCL: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AbCellera Biologics
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
562
CEO
Carl Lars G. Hansen, PhD
Website
www.abcellera.comHeadquarters
Vancouver, BC V5Y 0A1, CA
ABCL Financials
Key Financial Metrics (TTM)
Gross Margin
79%
Operating Margin
-3%
Net Income Margin
-2%
Return on Equity
-15%
Return on Capital
-17%
Return on Assets
-11%
Earnings Yield
-9.05%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$1.62B
Shares Outstanding
305.38M
Volume
226.64K
Avg. Volume
6.16M
Financials (TTM)
Gross Profit
$46.31M
Operating Income
-$217.10M
EBITDA
-$188.28M
Operating Cash Flow
-$131.30M
Capital Expenditure
-$42.77M
Free Cash Flow
-$174.07M
Cash & ST Invst.
$533.83M
Total Debt
$143.22M
AbCellera Biologics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$8.32M
+96.3%
Gross Profit
-$340.00K
-108.0%
Gross Margin
-4.09%
N/A
Market Cap
$1.62B
N/A
Market Cap/Employee
$2.72M
N/A
Employees
596
N/A
Net Income
-$43.17M
+5.4%
EBITDA
-$48.86M
+5.9%
Quarterly Fundamentals
Total Cash
$504.73M
-16.6%
Total Debt
$140.18M
+106.6%
Accounts Receivable
$115.73M
-8.6%
Inventory
$7.86M
N/A
Long Term Debt
$134.31M
+112.5%
Short Term Debt
$5.87M
+26.6%
Return on Assets
-11.01%
N/A
Return on Invested Capital
-16.82%
N/A
Free Cash Flow
-$37.35M
-68.3%
Operating Cash Flow
-$33.52M
-190.1%